Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT06167902
Eligibility Criteria:
Inclusion Criteria:
* Meet the diagnostic criteria for non-alcoholic fatty liver disease ;
* Aged 18-65 years old;
* ALT, AST, GGT≤2×Upper Limit Of Normal（ULN）;
* BMI≥28Kg/㎡;
* Patients signed the relevant informed consent on a voluntary basis.
Exclusion Criteria:
* Under 18 years old and over 65 years old;
* Allergic to the ingredients of ginseng oligopeptide preparation;
* Serum ALT, AST, GGT\>2ULN;
* Currently taking oral hepatoprotective drugs such as reduced glutathione, polyene phosphatidylcholine, and silibinin, etc.;
* Subjects participating in other clinical trials;
* Pregnant or lactating women;
* Complicated with serious diseases of the digestive system or other systems, such as chronic gastrointestinal diseases and chronic diseases causing digestive malabsorption,Kidney disease, hematological system or autoimmune diseases;
* Other populations that were deemed by the investigators to be ineligible for the trial may reduce or complicate enrollment patients with chemotherapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06167902
Study Brief:
Protocol Section:
NCT06167902